STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), ...

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

The Trump administration canceled the grants this week, citing concerns that novel mRNA vaccine technology remains “under-tested,” posing a risk to public health.

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its ...

CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

The researchers described the unprecedented speed of the oversight steps as being "through alternative procedures." In month ...

Amid the R&D and regulatory updates, BioNTech is also in the process of diversifying its supply base, Richardson said ... antibody BNT327 and its mRNA cancer immunotherapy platform.